How Do Providers Assess Antihypertensive Medication Adherence in Medical Encounters?

Bokhour, Barbara G.; Berlowitz, Dan R.; Long, Judith A.; Kressin, Nancy R.
June 2006
JGIM: Journal of General Internal Medicine;Jun2006, Vol. 21 Issue 6, p577
Academic Journal
BACKGROUND: Poor adherence to antihypertensives has been shown to be a significant factor in poor blood pressure (BP) control. Providers' communication with patients about their medication-taking behavior may be central to improving adherence. OBJECTIVE: The goal of this study was to characterize the ways in which providers ask patients about medication taking. DESIGN: Clinical encounters between primary care providers and hypertensive patients were audiotaped at 3 Department of Veterans' Affairs medical centers. PARTICIPANTS: Primary care providers (n=9) and African-American and Caucasian patients (n=38) who were diagnosed with hypertension (HTN). APPROACH: Transcribed audiotapes of clinical encounters were coded by 2 Investigators using qualitative analysis based on sociolinguistic techniques to identify, ways of asking about medication taking. Electronic medical records were reviewed after the visit to determine the BP measurement for the day of the taped encounter. RESULTS: Four different aspects of asking about medication were identified: structure, temporality, style and content. Open-ended questions generated the most discussion, while closed-ended declarative statements led to the least discussion. Collaborative style and use of lay language were also seen to facilitate discussions. In 39% of encounters, providers did not ask about medication taking. Among patients with uncontrolled HTN, providers did not ask about medications 33% of the time. CONCLUSION: Providers often do not ask about medication-taking behavior, and may not use the most effective communication strategies when they do. Focusing on the ways in which providers ask about patients' adherence to medications may improve BP control.


Related Articles

  • Organisational factors in relation to control of blood pressure: an observational study. Inkster, Melanie; Montgomery, Alan; Donnan, Peter; MacDonald, Tom; Sullivan, Frank; Fahey, Tom // British Journal of General Practice;Dec2005, Vol. 55 Issue 521, p931 

    Background Studies show that 60-75% of treated patients with hypertension in general practice, still do not reach the recommended blood pressure targets of <150/90 mmHg. Aim To investigate aspects of hypertension management in relation to sociodemographic variables, antihypertensive drug...

  • Drug management of hypertension in primary care. Hall, Gwen // Primary Health Care;Apr2006, Vol. 16 Issue 3, p27 

    The article reports on the drug management of hypertension in primary care in Great Britain. This condition continues to pose clinical and financial burdens on the National Health Service (NHS). The General Medical Services (GMS) contract offers incentives for improving the detection and control...

  • Efficacy and Safety of Amlodipine: A Comparative Study of Hypertensive Patients Treated at Primary- and Specialised-Care Centres. Valcárcel, Y.; Jiménez, R.; Hernández, V.; Arístegui, R.; Gil, A. // Clinical Drug Investigation;2006, Vol. 26 Issue 3, p125 

    BACKGROUND: This study set out to assess the safety and efficacy of amlodipine in two cohorts of patients who were attended in primary- and specialised-care centres, respectively. METHODS: Prospective, observational, multicentre pharmacovigilance study including patients aged >18 years who...

  • Predictors of Antihypertensive Drug Responses: Initial Data from a Placebo-Controlled, Randomized, Cross-Over Study With Four Antihypertensive Drugs (The GENRES Study). Hiltunen, Timo P.; Suonsyrjä, Timo; Hannila-Handelberg, Tuula; Paavonen, Kristian J.; Miettinen, Helena E.; Strandberg, Timo; Tikkanen, Ilkka; Tilvis, Reijo; Pentikäinen, Pertti J.; Virolainen, Juha; Kontula, Kimmo // American Journal of Hypertension;Mar2007, Vol. 20 Issue 3, p311 

    Background: Only a minority of hypertensive individuals is adequately controlled for their hypertension, partially because reliable predictors for efficient antihypertensive drug therapy are lacking. Methods: In a prospective, randomized, double-blind, cross-over, placebo-controlled study (The...

  • Resistant hypertension: a practical clinical approach. Muxfeldt, E S; de Souza, F; Salles, G F // Journal of Human Hypertension;Nov2013, Vol. 27 Issue 11, p657 

    Resistant hypertension (RH) is defined as an uncontrolled office blood pressure (BP) despite the use of at least three antihypertensive drugs. With an increasing prevalence, RH implies in a very high cardiovascular risk and needs a careful clinical approach, aiming to control BP and to reduce...

  • Hypertension in Infantile Polycystic Renal Disease. Rahill, W. Joseph; Rubin, Mitchell I. // Clinical Pediatrics;Apr1972, Vol. 11 Issue 4, p232 

    Two infants with polycystic renal disease and severe hypertension had studies of renal function and antihypertensive therapy. One infant with adequate renal function died with uncontrolled hypertenson. The second infant's blood pressure approached normal; now three and one-half years of age, he...

  • Fixed-Dose Combination Lercanidipine/Enalapril. Hair, Philip I.; Scot, Lesley J.; Perry, Caroline M. // Drugs;2007, Vol. 67 Issue 1, p95 

    â–´ Lercanidipine, a dihydropyridine calcium channel blocker, and enalapril, an ACE inhibitor, are established antihypertensive agents. A fixed-dose tablet formulation of lercanidipine/enalapril is approved in Germany for the treatment of hypertension in patients not responding to...

  • Progressive renal disease: Role of race and antihypertensive medications. Brazy, Peter C.; Fitzwilliam, James F. // Kidney International;Apr1990, Vol. 37 Issue 4, p1113 

    Hypertension is associated with an accelerated rate of decline in renal function in patients with chronic renal disease. To identify factors that might alter the rate of decline in renal function, we reviewed records of 200 patients from the Nephrology Clinic of the Durham VA Medical Center who...

  • Serum Calcium Level in Hypertension. Hazari, Mohammed Abdul Hannan; Arifuddin, Mehnaaz Sameera; Muzzakar, Syed; Reddy, Vontela Devender // North American Journal of Medical Sciences;Nov2012, Vol. 4 Issue 11, p569 

    Background: The alterations in extracellular calcium level may influence intracellular calcium level and possibly play a role in the pathogenesis of essential hypertension. Aim: The purpose was to find out the association between serum calcium levels and hypertension; and to compare the serum...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics